# Dermata Therapeutics, Inc.: Form 8-K, filed Feb 25, 2026

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: 8-K
- Filed: 2026-02-25
- Accepted by EDGAR: Feb 25, 2026, 16:05 ET
- Period: 2026-02-23
- Accession: 0001493152-26-008037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226008037/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000149315226008037/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000149315226008037/form8-k.htm

Filed Feb 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-008037. Last ingested by Listed: Nov 11, 2026, 00:26 ET. No prices; not investment advice.